MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from june 2025
public offering, net of...
$41,138K
Receipt of 2024 svb
convertible term loan second...
$5,000K
Proceeds from june 2025
public offering...
$4,004K
Proceeds from exercise of
warrants note 10
$1,385K
Maturities of investments
$30,866K
Realized gain on
investments
$4K
Net cash provided by
financing activities
$51,527K
Net cash provided by
(used in) investing...
$6,111K
Effect of exchange rate
changes on cash
$3K
Canceled cashflow
$24,759K
Net increase
(decrease) in cash, cash...
$8,176K
Canceled cashflow
$49,465K
Stock-based compensation
note 10, note 10, note...
$8,761K
Change in fair value of
contingent consideration...
$408K
Depreciation and
amortization note 4
$228K
Amortization of 2024 svb
convertible term loan...
$52K
Accrued liabilities
other-Nonrelated Party
$25K
Accounts
payable-Related Party
$8K
Accrued liabilities
other-Related Party
$6K
Purchase of investments
$24,755K
Purchase of property and
equipment
$3K
Loss on disposal of
property and equipment
$1K
Net cash used in
operating activities
-$49,465K
Canceled cashflow
$9,488K
Net loss
-$54,648K
Prepaid expenses and
other...
$1,204K
Accrued compensation
-$1,108K
Accounts
payable-Nonrelated Party
-$1,091K
Accrued clinical
liabilities
-$709K
Prepaid expenses and
other assets-Related...
$193K
Back
Back
Cash Flow
source: myfinsight.com
ACHIEVE LIFE SCIENCES, INC. (ACHV)
ACHIEVE LIFE SCIENCES, INC. (ACHV)